In Vivo Toxicity Evaluation of PEGylated CuInS2/ZnS Quantum Dots in BALB/c Mice

In recent years, quantum dots (QDs) have emerged as a potential contrast agent for bioimaging due to their bright luminescence and excellent photostability. However, the wide use of QDs in vivo has been limited due to underlying toxicity caused by leakage of heavy metals. Although non-cadmium QDs ha...

Full description

Bibliographic Details
Main Authors: Wenyi Zou, Li Li, Yajing Chen, Tingting Chen, Zhiwen Yang, Jie Wang, Dongmeng Liu, Guimiao Lin, Xiaomei Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2019.00437/full
_version_ 1798046046248501248
author Wenyi Zou
Wenyi Zou
Li Li
Yajing Chen
Tingting Chen
Zhiwen Yang
Jie Wang
Dongmeng Liu
Guimiao Lin
Xiaomei Wang
Xiaomei Wang
author_facet Wenyi Zou
Wenyi Zou
Li Li
Yajing Chen
Tingting Chen
Zhiwen Yang
Jie Wang
Dongmeng Liu
Guimiao Lin
Xiaomei Wang
Xiaomei Wang
author_sort Wenyi Zou
collection DOAJ
description In recent years, quantum dots (QDs) have emerged as a potential contrast agent for bioimaging due to their bright luminescence and excellent photostability. However, the wide use of QDs in vivo has been limited due to underlying toxicity caused by leakage of heavy metals. Although non-cadmium QDs have been developed to resolve this issue, a comprehensive understanding of the toxicity of these newly developed QDs remains elusive. In this study, we administered PEGylated copper indium sulfide/zinc sulfide (CuInS2/ZnS), which are typical non-cadmium QDs, and analyzed the long-term effects of these nanoparticles in BALB/c mice. Body weight, hematology, blood biochemistry, organ histology, and biodistribution were examined at different time points. We found no significant difference in body weight after injection of CuInS2/ZnS QDs. These CuInS2/ZnS QDs entered and were accumulated in major organs for 90 days post-injection. The majority of biochemical indicators were not significantly different between the QDs-treated group and the control group. In addition, no significant histopathological abnormalities were observed in the treated mice compared with the control mice. CuInS2/ZnS QDs did not lead to observable toxicity in vivo following either the administration of a high or low dose. Our research not only provides direct evidence of the bio-safety of CuInS2/ZnS QDs, but also a feasible method for evaluating nanoparticle toxicity.
first_indexed 2024-04-11T23:31:09Z
format Article
id doaj.art-6043f3dff7514769ab37ba8b047707dd
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-11T23:31:09Z
publishDate 2019-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-6043f3dff7514769ab37ba8b047707dd2022-12-22T03:57:07ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-04-011010.3389/fphar.2019.00437435178In Vivo Toxicity Evaluation of PEGylated CuInS2/ZnS Quantum Dots in BALB/c MiceWenyi Zou0Wenyi Zou1Li Li2Yajing Chen3Tingting Chen4Zhiwen Yang5Jie Wang6Dongmeng Liu7Guimiao Lin8Xiaomei Wang9Xiaomei Wang10College of Life Sciences and Oceanography, Shenzhen University, Shenzhen, ChinaDepartment of Physiology, School of Basic Medical Sciences, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, ChinaDepartment of Physiology, School of Basic Medical Sciences, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, ChinaDepartment of Physiology, School of Basic Medical Sciences, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, ChinaDepartment of Physiology, School of Basic Medical Sciences, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, ChinaDepartment of Physiology, School of Basic Medical Sciences, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, ChinaDepartment of Physiology, School of Basic Medical Sciences, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, ChinaDepartment of Physiology, School of Basic Medical Sciences, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, ChinaDepartment of Physiology, School of Basic Medical Sciences, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, ChinaCollege of Life Sciences and Oceanography, Shenzhen University, Shenzhen, ChinaDepartment of Physiology, School of Basic Medical Sciences, Shenzhen University Health Science Center, Shenzhen University, Shenzhen, ChinaIn recent years, quantum dots (QDs) have emerged as a potential contrast agent for bioimaging due to their bright luminescence and excellent photostability. However, the wide use of QDs in vivo has been limited due to underlying toxicity caused by leakage of heavy metals. Although non-cadmium QDs have been developed to resolve this issue, a comprehensive understanding of the toxicity of these newly developed QDs remains elusive. In this study, we administered PEGylated copper indium sulfide/zinc sulfide (CuInS2/ZnS), which are typical non-cadmium QDs, and analyzed the long-term effects of these nanoparticles in BALB/c mice. Body weight, hematology, blood biochemistry, organ histology, and biodistribution were examined at different time points. We found no significant difference in body weight after injection of CuInS2/ZnS QDs. These CuInS2/ZnS QDs entered and were accumulated in major organs for 90 days post-injection. The majority of biochemical indicators were not significantly different between the QDs-treated group and the control group. In addition, no significant histopathological abnormalities were observed in the treated mice compared with the control mice. CuInS2/ZnS QDs did not lead to observable toxicity in vivo following either the administration of a high or low dose. Our research not only provides direct evidence of the bio-safety of CuInS2/ZnS QDs, but also a feasible method for evaluating nanoparticle toxicity.https://www.frontiersin.org/article/10.3389/fphar.2019.00437/fullCuInS2/ZnS quantum dotsnanotoxicologynon-cadmiumtoxicityin vivo
spellingShingle Wenyi Zou
Wenyi Zou
Li Li
Yajing Chen
Tingting Chen
Zhiwen Yang
Jie Wang
Dongmeng Liu
Guimiao Lin
Xiaomei Wang
Xiaomei Wang
In Vivo Toxicity Evaluation of PEGylated CuInS2/ZnS Quantum Dots in BALB/c Mice
Frontiers in Pharmacology
CuInS2/ZnS quantum dots
nanotoxicology
non-cadmium
toxicity
in vivo
title In Vivo Toxicity Evaluation of PEGylated CuInS2/ZnS Quantum Dots in BALB/c Mice
title_full In Vivo Toxicity Evaluation of PEGylated CuInS2/ZnS Quantum Dots in BALB/c Mice
title_fullStr In Vivo Toxicity Evaluation of PEGylated CuInS2/ZnS Quantum Dots in BALB/c Mice
title_full_unstemmed In Vivo Toxicity Evaluation of PEGylated CuInS2/ZnS Quantum Dots in BALB/c Mice
title_short In Vivo Toxicity Evaluation of PEGylated CuInS2/ZnS Quantum Dots in BALB/c Mice
title_sort in vivo toxicity evaluation of pegylated cuins2 zns quantum dots in balb c mice
topic CuInS2/ZnS quantum dots
nanotoxicology
non-cadmium
toxicity
in vivo
url https://www.frontiersin.org/article/10.3389/fphar.2019.00437/full
work_keys_str_mv AT wenyizou invivotoxicityevaluationofpegylatedcuins2znsquantumdotsinbalbcmice
AT wenyizou invivotoxicityevaluationofpegylatedcuins2znsquantumdotsinbalbcmice
AT lili invivotoxicityevaluationofpegylatedcuins2znsquantumdotsinbalbcmice
AT yajingchen invivotoxicityevaluationofpegylatedcuins2znsquantumdotsinbalbcmice
AT tingtingchen invivotoxicityevaluationofpegylatedcuins2znsquantumdotsinbalbcmice
AT zhiwenyang invivotoxicityevaluationofpegylatedcuins2znsquantumdotsinbalbcmice
AT jiewang invivotoxicityevaluationofpegylatedcuins2znsquantumdotsinbalbcmice
AT dongmengliu invivotoxicityevaluationofpegylatedcuins2znsquantumdotsinbalbcmice
AT guimiaolin invivotoxicityevaluationofpegylatedcuins2znsquantumdotsinbalbcmice
AT xiaomeiwang invivotoxicityevaluationofpegylatedcuins2znsquantumdotsinbalbcmice
AT xiaomeiwang invivotoxicityevaluationofpegylatedcuins2znsquantumdotsinbalbcmice